2006
DOI: 10.1016/j.ijgo.2006.02.004
|View full text |Cite
|
Sign up to set email alerts
|

Gynaecological and obstetric management of women with inherited bleeding disorders

Abstract: 1. Inherited bleeding disorders should be considered in the differential diagnosis of all patients presenting with menorrhagia (II-2B). The graphical scoring system presented is a validated tool which offers a simple yet practical method that can be used by patients to quantify their blood loss (II-2B). 2. Because underlying bleeding disorders are frequent in women with menorrhagia, physicians should consider performing a hemoglobin/hematocrit, platelet count, ferritin, PT (INR) and APTT in women with menorrha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 49 publications
(4 citation statements)
references
References 53 publications
0
4
0
Order By: Relevance
“…As indicated in the study by Govorov et al , women with vWD appear to show a significantly increased incidence of postpartum hemorrhage compared to healthy controls, putting aside that the quantity of FVIII and vWF increase during pregnancy ( 25 ).…”
Section: Discussionmentioning
confidence: 98%
“…As indicated in the study by Govorov et al , women with vWD appear to show a significantly increased incidence of postpartum hemorrhage compared to healthy controls, putting aside that the quantity of FVIII and vWF increase during pregnancy ( 25 ).…”
Section: Discussionmentioning
confidence: 98%
“…Adolescents at risk of bleeding disorders should undergo testing for vWD. The von Willebrand panel should include; plasma von Willebrand factor (vWF) antigen and functional tests for vWF and factor VIII activity ( 32 , 34 ). Those with a blood type O will have lower levels of vWF than those who have blood type A or B.…”
Section: Discussionmentioning
confidence: 99%
“…Anti-fibrinolytics, NSAIDs, hormonal therapies (combined oral contraceptive pills (COCPs), progesterone-only pills (POPs), depot medroxy progesterone acetate, danazol, gonadotrophin-releasing hormone analogs and LNG-IUS), platelet transfusion, recombinant FVIIa (rFVIIa) and surgery are the various modalities available for treatment of GT-related HMB [ 14 – 16 ] (Fig. 1 ).…”
Section: Discussionmentioning
confidence: 99%